In vivo imaging of insulin receptors by PET

Preclinical evaluation of iodine-125 and iodine-124 labelled human insulin

P. Iozzo, S. Osman, M. Glaser, M. Knickmeier, E. Ferrannini, V. W. Pike, P. G. Camici, M. P. Law

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

[A14-*I]iodoinsulin was prepared for studies to assess the suitability of labeled iodoinsulin for positron emission tomography (PET). Iodine-125 was used to establish the methods and for preliminary studies in rats. Further studies and PET scanning in rats were carried out using iodine-124. Tissue and plasma radioactivity was measured as the uptake index (UI = {cpm·(g tissue)-1}/{cpm injected·(g body weight)-1}) at 1 to 40 min after intravenous injection of either [A14-125I]iodoinsulin or [A14-124I]iodoinsulin. For both radiotracers, initial clearance of radioactivity from plasma was rapid (T1/2 ∼ 1 min), reaching a plateau (UI = 2.8) at ∼ 5 min which was maintained for 35 min. Tissue biodistributions of the two radiotracers were comparable; at 10 min after injection, UI for myocardium was 2.4, liver, 4.0, pancreas, 5.4, brain, 0.17, kidney, 22, lung, 2.3, muscle, 0.54 and fat, 0.28. Predosing rats with unlabelled insulin reduced the UI for myocardium (0.95), liver (1.8), pancreas (1.2) and brain (0.08), increased that for kidney (61) but had no effect on that for lung (2.5), muscle (0.50) or fat (0.34). Analysis of radioactivity in plasma demonstrated a decrease of [125I]iodoinsulin associated with the appearance of labeled metabolites; the percentage of plasma radioactivity due to [125I]iodoinsulin was 40% at 5 min and 10% at 10 min. The heart, liver and kidneys were visualized using [124I]iodoinsulin with PET.

Original languageEnglish
Pages (from-to)73-82
Number of pages10
JournalNuclear Medicine and Biology
Volume29
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Insulin Receptor
Iodine
Positron-Emission Tomography
Insulin
Radioactivity
Kidney
Pancreas
Liver
Myocardium
Fats
Muscles
Lung
Brain
iodo-insulin
Intravenous Injections
Body Weight
Injections

Keywords

  • [I]iodoinsulin
  • Biodistribution in rat
  • Insulin receptors
  • Metabolism in rat
  • Positron emission tomography

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

In vivo imaging of insulin receptors by PET : Preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. / Iozzo, P.; Osman, S.; Glaser, M.; Knickmeier, M.; Ferrannini, E.; Pike, V. W.; Camici, P. G.; Law, M. P.

In: Nuclear Medicine and Biology, Vol. 29, No. 1, 2002, p. 73-82.

Research output: Contribution to journalArticle

Iozzo, P. ; Osman, S. ; Glaser, M. ; Knickmeier, M. ; Ferrannini, E. ; Pike, V. W. ; Camici, P. G. ; Law, M. P. / In vivo imaging of insulin receptors by PET : Preclinical evaluation of iodine-125 and iodine-124 labelled human insulin. In: Nuclear Medicine and Biology. 2002 ; Vol. 29, No. 1. pp. 73-82.
@article{52ea3ff771d54c5582ff135e3eaa2d46,
title = "In vivo imaging of insulin receptors by PET: Preclinical evaluation of iodine-125 and iodine-124 labelled human insulin",
abstract = "[A14-*I]iodoinsulin was prepared for studies to assess the suitability of labeled iodoinsulin for positron emission tomography (PET). Iodine-125 was used to establish the methods and for preliminary studies in rats. Further studies and PET scanning in rats were carried out using iodine-124. Tissue and plasma radioactivity was measured as the uptake index (UI = {cpm·(g tissue)-1}/{cpm injected·(g body weight)-1}) at 1 to 40 min after intravenous injection of either [A14-125I]iodoinsulin or [A14-124I]iodoinsulin. For both radiotracers, initial clearance of radioactivity from plasma was rapid (T1/2 ∼ 1 min), reaching a plateau (UI = 2.8) at ∼ 5 min which was maintained for 35 min. Tissue biodistributions of the two radiotracers were comparable; at 10 min after injection, UI for myocardium was 2.4, liver, 4.0, pancreas, 5.4, brain, 0.17, kidney, 22, lung, 2.3, muscle, 0.54 and fat, 0.28. Predosing rats with unlabelled insulin reduced the UI for myocardium (0.95), liver (1.8), pancreas (1.2) and brain (0.08), increased that for kidney (61) but had no effect on that for lung (2.5), muscle (0.50) or fat (0.34). Analysis of radioactivity in plasma demonstrated a decrease of [125I]iodoinsulin associated with the appearance of labeled metabolites; the percentage of plasma radioactivity due to [125I]iodoinsulin was 40{\%} at 5 min and 10{\%} at 10 min. The heart, liver and kidneys were visualized using [124I]iodoinsulin with PET.",
keywords = "[I]iodoinsulin, Biodistribution in rat, Insulin receptors, Metabolism in rat, Positron emission tomography",
author = "P. Iozzo and S. Osman and M. Glaser and M. Knickmeier and E. Ferrannini and Pike, {V. W.} and Camici, {P. G.} and Law, {M. P.}",
year = "2002",
doi = "10.1016/S0969-8051(01)00286-4",
language = "English",
volume = "29",
pages = "73--82",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - In vivo imaging of insulin receptors by PET

T2 - Preclinical evaluation of iodine-125 and iodine-124 labelled human insulin

AU - Iozzo, P.

AU - Osman, S.

AU - Glaser, M.

AU - Knickmeier, M.

AU - Ferrannini, E.

AU - Pike, V. W.

AU - Camici, P. G.

AU - Law, M. P.

PY - 2002

Y1 - 2002

N2 - [A14-*I]iodoinsulin was prepared for studies to assess the suitability of labeled iodoinsulin for positron emission tomography (PET). Iodine-125 was used to establish the methods and for preliminary studies in rats. Further studies and PET scanning in rats were carried out using iodine-124. Tissue and plasma radioactivity was measured as the uptake index (UI = {cpm·(g tissue)-1}/{cpm injected·(g body weight)-1}) at 1 to 40 min after intravenous injection of either [A14-125I]iodoinsulin or [A14-124I]iodoinsulin. For both radiotracers, initial clearance of radioactivity from plasma was rapid (T1/2 ∼ 1 min), reaching a plateau (UI = 2.8) at ∼ 5 min which was maintained for 35 min. Tissue biodistributions of the two radiotracers were comparable; at 10 min after injection, UI for myocardium was 2.4, liver, 4.0, pancreas, 5.4, brain, 0.17, kidney, 22, lung, 2.3, muscle, 0.54 and fat, 0.28. Predosing rats with unlabelled insulin reduced the UI for myocardium (0.95), liver (1.8), pancreas (1.2) and brain (0.08), increased that for kidney (61) but had no effect on that for lung (2.5), muscle (0.50) or fat (0.34). Analysis of radioactivity in plasma demonstrated a decrease of [125I]iodoinsulin associated with the appearance of labeled metabolites; the percentage of plasma radioactivity due to [125I]iodoinsulin was 40% at 5 min and 10% at 10 min. The heart, liver and kidneys were visualized using [124I]iodoinsulin with PET.

AB - [A14-*I]iodoinsulin was prepared for studies to assess the suitability of labeled iodoinsulin for positron emission tomography (PET). Iodine-125 was used to establish the methods and for preliminary studies in rats. Further studies and PET scanning in rats were carried out using iodine-124. Tissue and plasma radioactivity was measured as the uptake index (UI = {cpm·(g tissue)-1}/{cpm injected·(g body weight)-1}) at 1 to 40 min after intravenous injection of either [A14-125I]iodoinsulin or [A14-124I]iodoinsulin. For both radiotracers, initial clearance of radioactivity from plasma was rapid (T1/2 ∼ 1 min), reaching a plateau (UI = 2.8) at ∼ 5 min which was maintained for 35 min. Tissue biodistributions of the two radiotracers were comparable; at 10 min after injection, UI for myocardium was 2.4, liver, 4.0, pancreas, 5.4, brain, 0.17, kidney, 22, lung, 2.3, muscle, 0.54 and fat, 0.28. Predosing rats with unlabelled insulin reduced the UI for myocardium (0.95), liver (1.8), pancreas (1.2) and brain (0.08), increased that for kidney (61) but had no effect on that for lung (2.5), muscle (0.50) or fat (0.34). Analysis of radioactivity in plasma demonstrated a decrease of [125I]iodoinsulin associated with the appearance of labeled metabolites; the percentage of plasma radioactivity due to [125I]iodoinsulin was 40% at 5 min and 10% at 10 min. The heart, liver and kidneys were visualized using [124I]iodoinsulin with PET.

KW - [I]iodoinsulin

KW - Biodistribution in rat

KW - Insulin receptors

KW - Metabolism in rat

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=0036151095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036151095&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(01)00286-4

DO - 10.1016/S0969-8051(01)00286-4

M3 - Article

VL - 29

SP - 73

EP - 82

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 1

ER -